These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18498967)

  • 1. Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results.
    Linthorst GE; Poorthuis BJ; Hollak CE
    J Am Coll Cardiol; 2008 May; 51(21):2082; author reply 2082-3. PubMed ID: 18498967
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.
    Monserrat L; Gimeno-Blanes JR; Marín F; Hermida-Prieto M; García-Honrubia A; Pérez I; Fernández X; de Nicolas R; de la Morena G; Payá E; Yagüe J; Egido J
    J Am Coll Cardiol; 2007 Dec; 50(25):2399-403. PubMed ID: 18154965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.
    Havndrup O; Christiansen M; Stoevring B; Jensen M; Hoffman-Bang J; Andersen PS; Hasholt L; Nørremølle A; Feldt-Rasmussen U; Køber L; Bundgaard H
    Eur J Heart Fail; 2010 Jun; 12(6):535-40. PubMed ID: 20498269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy.
    Ackerman MJ; Landstrom AP
    J Am Coll Cardiol; 2007 Dec; 50(25):2404-5. PubMed ID: 18154966
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and genetic analysis of Fabry disease: report of six cases including three heterozygous females.
    Nagasaki A; Nishie W; Sato K; Oba I; Noguchi E; Akitsu H; Sawamura D; Shimizu H
    J Dermatol Sci; 2008 Oct; 52(1):61-4. PubMed ID: 18555667
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke.
    Brouns R; Sheorajpanday R; Braxel E; Eyskens F; Baker R; Hughes D; Mehta A; Timmerman T; Vincent MF; De Deyn PP
    Clin Neurol Neurosurg; 2007 Jul; 109(6):479-84. PubMed ID: 17509753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
    Demontis R
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac manifestations of Fabry's disease: a story of mother and son.
    Moses H; Yarnoz MJ; Guglin M
    Congest Heart Fail; 2009; 15(2):93-5. PubMed ID: 19379456
    [No Abstract]   [Full Text] [Related]  

  • 10. Fabry disease in childhood.
    Desnick RJ; Brady RO
    J Pediatr; 2004 May; 144(5 Suppl):S20-6. PubMed ID: 15126980
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurological manifestations of Fabry disease in female carriers.
    Bird TD; Lagunoff D
    Ann Neurol; 1978 Dec; 4(6):537-40. PubMed ID: 217299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study.
    Hagège AA; Caudron E; Damy T; Roudaut R; Millaire A; Etchecopar-Chevreuil C; Tran TC; Jabbour F; Boucly C; Prognon P; Charron P; Germain DP;
    Heart; 2011 Jan; 97(2):131-6. PubMed ID: 21062768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients.
    De Schoenmakere G; Poppe B; Wuyts B; Claes K; Cassiman D; Maes B; Verbeelen D; Vanholder R; Kuypers DR; Lameire N; De Paepe A; Terryn W
    Nephrol Dial Transplant; 2008 Dec; 23(12):4044-8. PubMed ID: 18596132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis of a Chinese patient with Fabry disease.
    Lam CW; Mak YT; Lo YM; Tong SF; To KF; Lai FM
    Chin Med J (Engl); 2000 Feb; 113(2):186-8. PubMed ID: 11775551
    [No Abstract]   [Full Text] [Related]  

  • 15. Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5.
    Brokalaki EI; Hentschke M; Grabbe S; Jansen T
    Eur J Med Res; 2006 Jul; 11(7):306-8. PubMed ID: 16899426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis.
    Seo J; Kim M; Hong GR; Kim DS; Son JW; Cho IJ; Shim CY; Chang HJ; Ha JW; Chung N
    J Hum Genet; 2016 Sep; 61(9):775-80. PubMed ID: 27225851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey.
    Elliott P; Baker R; Pasquale F; Quarta G; Ebrahim H; Mehta AB; Hughes DA;
    Heart; 2011 Dec; 97(23):1957-60. PubMed ID: 21890869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Fabry disease using genetic testing.
    Weidemann F; Niemann M
    Eur J Heart Fail; 2010 Jun; 12(6):530-1. PubMed ID: 20498267
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin.
    Pisani A; Riccio E; Cianciaruso B; Imbriaco M
    J Nephrol; 2011; 24(6):806-8. PubMed ID: 22058028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
    Ferreira S; Valbuena C; Carvalho F; Oliveira JP
    Hum Genet; 2009 Aug; 126(2):352. PubMed ID: 19694060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.